Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer drug resistance is a significant challenge in therapy, often stemming from altered drug metabolism or target modification.
• This resistance limits the efficacy of chemotherapeutics and negatively impacts patient outcomes.
• Nanotechnology has emerged as a potential strategy to mitigate these issues.

Purpose of the Study:

• To review the factors contributing to cancer drug resistance.
• To explore nanobiotechnological approaches for overcoming drug resistance in breast cancer.
• To provide insights for researchers developing novel nanobiotechnological methods.

Main Methods:

• Literature review focusing on cancer drug resistance mechanisms.
• Analysis of nanobiotechnological strategies applied to cancer therapy.
• Synthesis of information relevant to breast cancer research and treatment.

Main Results:

• Nanotechnological approaches can protect drugs from enzymatic degradation, thereby lowering side effects.
• These methods have shown potential to increase patient compliance and survival rates.
• Understanding resistance factors is crucial for developing effective nanomedicines.

Conclusions:

• Nanobiotechnology presents a viable strategy to combat cancer drug resistance, particularly in breast cancer.
• Further research and development in nanobiotechnological methods are essential for improving cancer treatment modalities.
• This review offers guidance for researchers aiming to enhance breast cancer therapies through nanotechnology.